$55.63
-0.31-0.55%
Last update: 11:26 AM
15 minutes delayed
Comments
Loading...
Cytokinetics (CYTK) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCytokinetics (NASDAQ:CYTK) Stock Quotes, Forecast and News Summary
Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.
| Open | $54.99 |
| Close | - |
| Volume / Avg. | 1.21M / 1.40M |
| Day Range | $53.26 - $56.10 |
| 52 Wk Range | 25.98 - 110.25 |
| Market Cap | $6.55B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 23.64% |
| Days to Cover | 17.5 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cytokinetics Inc
Sector
Health Care
Industry
Biotechnology
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for disea...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cytokinetics (CYTK) stock?
You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.
Who are Cytokinetics (CYTK) competitors?
Other companies in Cytokinetics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Sarepta Therapeutics (NASDAQ:SRPT).
What is the forecast, or price target, for Cytokinetics (CYTK) stock?
Cytokinetics has a consensus price target of $75.10.
What is the current price for Cytokinetics (CYTK)?
The stock price for Cytokinetics (NASDAQ: CYTK) is $55.63 last updated September 19, 2024 at 11:26 AM EDT.
Does Cytokinetics (CYTK) pay a dividend?
There are no upcoming dividends for Cytokinetics.
When is Cytokinetics (NASDAQ:CYTK) reporting earnings?
Cytokinetics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Cytokinetics (CYTK) going to split?
There is no upcoming split for Cytokinetics.
What sector and industry does Cytokinetics (CYTK) operate in?
Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.